SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.
Liu, Ju-E; Liu, Xiao-Ying; Chen, Sheng; Zhang, Yan; Cai, Li-Yun; Yang, Min; Lai, Wei-Hua; Ren, Bin; Zhong, Shi-Long.
Eur J Clin Pharmacol
; 73(11): 1409-1416, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28812116
Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.
Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia.
Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture.
EVALUATION OF TREATMENT EFFICACY IN PATIENTS WITH NON-ALCOHOLIC-STEATOHEPATITIS AND HETEROZYGOTIC FAMILIAL HYPERCHOLESTEROLEMIA.
Ispol'zovanie farmakogeneticheskogo testirovaniia dlia predotvrashcheniia nezhelatel'nykh lekarstvennykh reaktsii pri terapii statinami.
Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.
Simvastatin-induced myopathy with concomitant use of cyclosporine: case report.
Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.